Report #2849841

Received Jul 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Urticaria

Symptom narrative

Hive reaction; This non-serious case was reported by a consumer and described the occurrence of hives in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced hives (Verbatim: Hive reaction). The outcome of the hives was not reported. It was unknown if the reporter considered the hives to be related to Shingrix. It was unknown if the company considered the hives to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JUL-2025 The Shingrix vaccine gave a hive reaction on the first dose, so he/she chose to skip the second dose.